南风轻轻，中药飘香。 2024年12月19日，习近平总书记在澳门科技大学考察时指出："中医药是中华文明的瑰宝，传承创新发 展中医药是件大事。要把这一祖先留给我们的宝贵财富继承好、发展好、利用好，推动中医药走向世 界。" 2018年10月22日，习近平总书记考察珠海横琴新区粤澳合作中医药科技产业园时强调："中医药学是中 华文明的瑰宝。要深入发掘中医药宝库中的精华，推进产学研一体化，推进中医药产业化、现代化，让 中医药走向世界。" 总书记两次考察，格外关注中医药。"十五五"规划建议提出："推进中医药传承创新，促进中西医结 合。"中医药振兴发展迎来天时、地利、人和的有利时机。 近年来，广东省出台一系列促进中医药传承创新发展的重大举措，全面推进国家中医药综合改革示范区 建设，打造粤港澳大湾区中医药高地，助力中医药扬帆出海，续写岐黄之术的新时代篇章。 一株小草改变世界，一纸经方传承千载，一缕药香穿越古今，一根银针贯通中西。古老的中医药薪火相 传、历久弥新，成为一张亮眼的"中国名片"。 从一只蜂看中医特色 冰箱里堆满"调料包"，厨房就是"中药房"，一年四季都在吃药膳、煲靓汤、喝凉茶。在广东，几乎人人 都能说出一两个养生药 ...

（来源：衢州日报） 转自：衢州日报 2026年，国家中医药局将组织实施"西学中"骨干人才培训，遴选3200名热爱中医药、临床基础好的西医 医师进行中医培训，培养一批善用中西医结合诊疗方法的骨干人才，为人民群众提供更加优质便捷的中 西医结合诊疗服务，同时带动各地开展西医学习中医工作，推动中西医协同发展，共同服务人民健康的 能力水平得到持续提升。 据新华社 进入"十五五"时期，我国面临人口老龄化加速、慢性病负担加重、多重疾病威胁并存等复杂挑战，更加 需要充分发挥两种医学的叠加优势，着力为人民群众提供更高水平的中西医结合服务，更好地保障人民 生命安全和身体健康。 周景玉介绍，我国西医学习中医具有优良传统，早在1955年就举办了首届西医离职学习中医研究班，随 后相继举办了多期"西学中"班，涌现出以屠呦呦、陈可冀等为代表的中西医结合大家，产出了青蒿素、 血瘀证与活血化瘀研究等重大成果，为护佑人民健康作出了重要贡献。 国家中医药局人教司副司长周景玉近日在国家卫健委发布会上表示，近年来国家卫生健康委、国家中医 药管理局持续放大中西医互补优势，在预防、治疗、康复、人才培养、科学研究等工作中全面推进中西 医协同，一些重大疑难疾 ...

Group 1 - The core viewpoint of the news indicates that the Artemisinin concept sector has experienced a decline of 0.85%, ranking among the top losers in the concept sector, with companies like Delong Huineng, Rundu Co., and Kunming Pharmaceutical Group showing significant declines [1] Group 2 - The top gainers in today's concept sectors include Lead Metal with a rise of 5.01%, Zinc Metal at 4.83%, and Gold Concept at 3.82%, while the top losers include Duty-Free Shops at -1.16% and Trust Concept at -1.09% [2] - The net outflow of main funds from the Artemisinin concept sector today was 0.24 billion yuan, with six stocks experiencing net outflows, led by Delong Huineng with a net outflow of 36.54 million yuan [2] - The stocks with the highest net inflows include Fosun Pharma, New Hecheng, and Zhejiang Medicine, with net inflows of 32.34 million yuan, 19.09 million yuan, and 9.40 million yuan respectively [2]

Core Insights - The article discusses the emerging field of biomanufacturing, which is recognized as one of the six future industries in China's 14th Five-Year Plan, highlighting its potential to transform various sectors through innovative production methods [11][32][34]. Group 1: Definition and Process of Biomanufacturing - Biomanufacturing involves utilizing biological entities, such as microorganisms and plant or animal cells, to metabolize raw materials into desired products, effectively turning cells into small factories [5][26]. - The process includes maintaining optimal conditions for cell growth, such as temperature and pH, and providing sufficient nutrients like carbon dioxide and hydrolyzed agricultural waste [5][26]. - The production capabilities of biomanufacturing can replace traditional agricultural methods, as seen with artemisinin production, which can be synthesized in a single container rather than requiring extensive farming [32][34]. Group 2: Market Potential and Industry Growth - The biomanufacturing industry in China reached a total scale of 1.1 trillion yuan during the 14th Five-Year Plan period, indicating significant growth potential [11][32]. - China's unified large market and comprehensive manufacturing system provide a strong foundation for developing new fields such as bio-based materials and biopharmaceuticals [34]. - The integration of biomanufacturing with over two-thirds of existing industries, including traditional chemical sectors, presents opportunities for efficiency improvements and greener production methods [34]. Group 3: Technological Advancements and Innovations - Recent breakthroughs in life sciences and synthetic biology, including gene sequencing and editing technologies, are being widely applied in biomanufacturing, leading to transformative changes in production methods [9][30]. - The establishment of national key laboratories and innovation platforms has positioned China as a leader in biomanufacturing research, with over 20% of global publications and patent applications in this field [36][37]. - The development of artificial intelligence-assisted tools for synthetic biology is enhancing the efficiency of strain design and selection processes, facilitating the production of specific therapeutic compounds [34][36]. Group 4: Infrastructure and Support for Startups - The construction of pilot testing platforms is crucial for supporting biomanufacturing startups, allowing them to transition from laboratory research to large-scale production [39][41]. - Regions like Hunan are investing in infrastructure to support biomanufacturing, including a 330-acre acceleration factory set to accommodate multiple startups for large-scale production by 2026 [39][41]. - Local governments are also creating supportive regulations and funding mechanisms to foster the growth of biomanufacturing clusters, enhancing the industry's long-term viability [41]. Group 5: Future Outlook - The rapid development and market expansion of biomanufacturing in China indicate a promising future, with ongoing efforts to innovate and apply biomanufactured products across various sectors [22][43].

Core Concept - Biomanufacturing is identified as one of the six future industries in China's 14th Five-Year Plan, utilizing biological processes to produce materials and products from raw materials through the metabolic activities of microorganisms and cells [1][10]. Group 1: Definition and Process - Biomanufacturing involves using biological entities, such as microorganisms and plant or animal cells, to metabolize raw materials into desired products, integrating industrial biotechnology with engineering principles for large-scale production [3][5]. - The process is likened to "raising cells," where conditions such as temperature and pH are controlled to optimize the production of materials, fuels, food, pharmaceuticals, and chemicals [3][5]. Group 2: Applications and Benefits - The production of PHA (polyhydroxyalkanoates), a biodegradable polymer, exemplifies biomanufacturing's potential, with over 70 different types developed for use in everyday products, pharmaceuticals, and textiles [8]. - Biomanufacturing offers environmentally friendly production methods, with products like biodegradable straws expected to decompose within 9 to 12 months [8]. Group 3: Market Potential and Growth - The biomanufacturing industry in China reached a total scale of 1.1 trillion yuan during the 14th Five-Year Plan period, indicating significant growth potential [10]. - China's advantages include a unified large market and the world's most complete manufacturing system, which can facilitate the development of new fields such as bio-based materials and biopharmaceuticals [10]. Group 4: Technological Advancements - Recent breakthroughs in life sciences and synthetic biology, including gene sequencing and editing technologies, are being widely applied in biomanufacturing, transforming production methods and potentially impacting daily life [8][12]. - The establishment of national key laboratories and innovation platforms has positioned technological innovation as a driving force for the development of biomanufacturing [12]. Group 5: Infrastructure and Support - The construction of pilot-scale platforms is crucial for transitioning from laboratory research to production, with the Ministry of Industry and Information Technology announcing the first batch of biomanufacturing pilot capacity construction platforms [14]. - Regions like Changde are actively fostering biomanufacturing as a key industry, with plans for acceleration factories and supportive regulations to aid startup companies in scaling production [14][16]. Group 6: Investment and Market Development - Large enterprises and investment institutions are increasingly involved in the biomanufacturing sector, contributing to the entire industry chain from innovation to market application [16]. - The rapid development and market exploration in biomanufacturing reflect a significant shift towards sustainable production methods in various industries [16].

Group 1 - The establishment of the Qinghao Innovation Research Center at Guangzhou Nanfang College is a key initiative to deepen industry-education integration and respond to the national strategy of "inheritance and innovation in traditional Chinese medicine" [1] - The research center aims to promote technological innovation, industrial upgrading, and talent cultivation in the field of Qinghao through collaboration among schools, enterprises, government, and research institutions [1] - The center will focus on systematic research in areas such as the protection of Qinghao genetic resources, breeding of quality varieties, standardized planting techniques, and the mechanism of Qinghao's role in antiviral applications [1] Group 2 - The establishment of the Qinghao Innovation Research Center aligns with the "Double Hundred Action" and serves the "Hundred Million Project," aiming to facilitate deep cooperation with local medical institutions [2] - The center's academic advisors include prominent professors who will contribute to the research and development efforts [2] - Experts and scholars engaged in discussions on various aspects of Qinghao research, providing diverse perspectives on its development and industrialization [2]

Core Viewpoint - The article highlights the significant advancements in malaria treatment, particularly focusing on the development of a new drug, Ganaplacide–Lumefantrine (GanLum), by Novartis, which shows promise against drug-resistant malaria strains [8][10]. Group 1: Historical Context and Current Situation - In 1972, Chinese scientists, led by Tu Youyou, extracted artemisinin from sweet wormwood, significantly reducing malaria mortality rates and earning Tu the Nobel Prize in 2015 [2]. - The compound artemisinin led to the development of artemether-lumefantrine, marketed as Coartem, which became a first-line treatment for malaria and has saved millions of lives since its approval in 1999 [3][5]. - Malaria, caused by Plasmodium parasites transmitted through mosquito bites, infects hundreds of millions globally each year, resulting in nearly 600,000 deaths, primarily among children under five [5]. Group 2: New Drug Development - Novartis announced promising results from Phase 3 clinical trials for GanLum, a new imidazopyridine-based antimalarial drug, which targets the internal protein transport system necessary for the survival of the malaria parasite in human red blood cells [8]. - The clinical trial involved 1,688 malaria patients across 12 African countries, showing GanLum cleared artemisinin-resistant malaria mutations in about 47 hours, compared to 71 hours for artemether-lumefantrine [8]. - GanLum achieved a cure rate of 97.4%, surpassing the 94% cure rate of the standard treatment, with comparable safety profiles [8]. Group 3: Implications and Future Prospects - GanLum is expected to be effective in areas with known artemisinin resistance and can also be used in regions without resistance to slow down the development of drug resistance [10]. - Novartis is currently seeking regulatory approval for GanLum, with expectations for market availability within 12-18 months, marking the first new class of antimalarial drug approved since artemether-lumefantrine [11].

Group 1 - The core viewpoint of the news is that the Artemisinin concept sector experienced a slight increase of 0.40%, ranking 9th among concept sectors in terms of growth, with two stocks rising and several others declining [1] - Among the stocks in the Artemisinin concept sector, Delong Huineng reached a daily limit increase, while Baihua Pharmaceutical, Fosun Pharmaceutical, and Zhejiang Pharmaceutical saw declines of 1.91%, 1.42%, and 1.30% respectively [1] - The overall market saw a net outflow of 300 million yuan from the Artemisinin concept sector, with only one stock, Rundu Co., receiving a net inflow of 246,700 yuan, marking it as the top stock in terms of net inflow [2] Group 2 - The top-performing concept sectors today included China-Korea Free Trade Zone with an increase of 1.45%, while the worst-performing sector was the military equipment restructuring concept, which fell by 2.91% [2] - The trading volume and turnover rates for stocks in the Artemisinin concept sector varied, with Rundu Co. showing a turnover rate of 1.66% and a slight decline of 0.23%, while other stocks like Baihua Pharmaceutical and Zhejiang Pharmaceutical experienced larger declines and negative net inflows [2]

Core Viewpoint - The articles highlight the significant contributions of women in various fields, emphasizing their roles in advancing society and the economy, particularly in the context of China's modernization and development efforts [1][5]. Group 1: Contributions in Science and Technology - Tu Youyou, a recipient of the "Republic Medal," discovered artemisinin, which significantly reduced malaria mortality rates, saving millions of lives globally [7]. - Shan Xinghua led the development of the 12306 China Railway ticketing system, establishing it as a leading real-time ticketing platform worldwide [8]. - Liang Daihua, a director at Heilongjiang Gushi Biological Group, developed over a hundred nutritional plans that helped farmers increase their income by over 1 billion [10]. Group 2: Participation in Governance and Democracy - The proportion of female representatives in the National People's Congress (NPC) has increased, with 790 women representing 26.5% in 2023, up by 3.1 and 1.6 percentage points from previous sessions [13]. - Female representatives in the NPC proposed 29,328 suggestions, criticisms, and opinions from 2018 to 2025, accounting for 42.3% of the total [14]. - Women accounted for 42.3% of judges and 43.78% of prosecutors in 2024, with female jurors making up 51.5% [15]. Group 3: Cultural Contributions - Fan Jinshi, honorary director of the Dunhuang Research Institute, has made significant contributions to the protection and preservation of the Dunhuang Mogao Caves, establishing regulations and methods for cultural heritage protection [18]. - Women represent 25% of the 3,997 national-level intangible cultural heritage representatives, with 57% of the 51,000 training participants being women [20]. - Young women are becoming key figures in the "national trend" and the living inheritance of intangible cultural heritage, integrating it into contemporary life [21]. Group 4: Sports Achievements - The Chinese women's volleyball team achieved a remarkable victory at the 2023 Hangzhou Asian Games, winning gold for the ninth time, showcasing the spirit of teamwork and resilience [23]. Group 5: Community and Social Services - The "Peaceful Big Sister" team utilizes traditional Chinese mediation methods to resolve disputes and conflicts within communities [24]. - Wang Lanhua, a retired community committee director, has led volunteer services for over 20 years, addressing the needs of the elderly and children in her community [27]. - Women's volunteer fire brigades in Mushan Village conduct fire safety drills and promote fire safety knowledge to protect their community [29]. Group 6: Environmental Protection and Green Development - Yin Yuzhen has transformed over 70,000 acres of desert into arable land, contributing to ecological restoration and sustainable agriculture [31]. - Zhang Jinmei has dedicated decades to cultivating suitable tree species for high-altitude regions, promoting afforestation efforts [32]. - A women's team in Kunming has been actively involved in cleaning up the Dianchi Lake area, contributing to local environmental protection [34].

Core Viewpoint - The article highlights the contributions of patriotic scientists in China, emphasizing their dedication and sacrifices for the nation's progress and development [1][16]. Group 1: Contributions of Scientists - Qian Weichang, despite his initial struggles in physics, chose to pursue science to serve the country, embodying the spirit of "the needs of the nation are my profession" [4]. - Hua Luogeng, upon hearing about the founding of New China, wrote an open letter urging overseas students to return and contribute to the nation, inspiring many top scientists to come back [6]. - Huang Xuhua dedicated 30 years to developing China's first nuclear submarine, prioritizing national duty over family [6]. - Gu Fangzhou developed a polio vaccine, personally testing it on his own child to ensure its safety, ultimately saving millions of children [6]. Group 2: Research and Innovations - Yuan Longping spent seven years searching for a natural male-sterile rice variety, leading to breakthroughs in hybrid rice research, aiming to eliminate hunger [8]. - Tu Youyou, through extensive research, developed artemisinin, a drug that has saved approximately 6.2 million lives globally [11]. - Deng Jiaxian risked his life during a nuclear test to collect debris, demonstrating his commitment to national security and scientific advancement [13]. - Nan Rendong dedicated 22 years to the construction of the world's largest radio telescope, FAST, showcasing perseverance in scientific endeavors [15]. Group 3: National Pride and Innovation - Ma Weiming led a 20-year effort to develop a key technology for naval power systems, achieving a breakthrough that surpassed American technology [15]. - The article concludes with a reflection on the sacrifices made by these scientists, emphasizing that the nation's stability and progress are due to their relentless efforts and dedication [16].